Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to $68.1 million.

  • Organogenesis Holdings' Cash & Current Investments fell 2824.94% to $68.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.1 million, marking a year-over-year decrease of 2824.94%. This contributed to the annual value of $136.2 million for FY2024, which is 3049.03% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Cash & Current Investments stood at $68.1 million, which was down 2824.94% from $78.4 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Cash & Current Investments registered a high of $136.2 million during Q4 2024, and its lowest value of $487000.0 during Q3 2021.
  • Its 5-year average for Cash & Current Investments is $84.5 million, with a median of $94.9 million in 2024.
  • Per our database at Business Quant, Organogenesis Holdings' Cash & Current Investments soared by 2208090.35% in 2022 and then tumbled by 2824.94% in 2025.
  • Organogenesis Holdings' Cash & Current Investments (Quarter) stood at $114.5 million in 2021, then fell by 9.81% to $103.3 million in 2022, then rose by 1.01% to $104.3 million in 2023, then soared by 30.49% to $136.2 million in 2024, then plummeted by 49.97% to $68.1 million in 2025.
  • Its Cash & Current Investments was $68.1 million in Q3 2025, compared to $78.4 million in Q2 2025 and $117.0 million in Q1 2025.